Evercore ISI raised the firm’s price target on Hinge Health (HNGE) to $65 from $60 and keeps an Outperform rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential
- Hinge Health price target raised to $67 from $57 at Morgan Stanley
- Hinge Health: Strong Buy Rating Driven by AI Innovation and Operational Efficiency
- Hinge Health price target raised to $66 from $63 at Stifel
- Hinge Health initiated with a Neutral at Baird